Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Cancer Treatment and Research Communications|March 28, 2025
Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in SpainAntonio Calles, Mirian Alonso, Paloma Martín-Martorell, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2009
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patientsVicente Alberola Candel, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, et al.
The New England Journal of Medicine|December 3, 2010
Adjuvant docetaxel for high-risk, node-negative breast cancerMiguel Martín, Miguel A Seguí, Antonio Antón, et al.
JAMA Oncology|July 17, 2015
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC TrialNiki Karachaliou, Clara Mayo-de las Casas, Cristina Queralt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutationsRafael Rosell, Miguel Angel Molina, Carlota Costa, et al.
BMC Cancer|March 7, 2021
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer GroupMariano Provencio, Josefa Terrasa, Pilar Garrido, et al.
Cancer Research|February 10, 2011
Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer riskThorunn Rafnar, Patrick Sulem, Soren Besenbacher, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2025
Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trialDolores Isla, Jon Zugazagoitia, Edurne Arriola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung CancerMelina Peressini, Rosario Garcia-Campelo, Bartomeu Massuti, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 21, 2024
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapyAna Gómez Rueda, Álvaro Taus, Rosa Álvarez Álvarez, et al.
Pageof 15